Free Trial

Eastern Bank Has $57 Million Stock Position in Procter & Gamble Company (The) $PG

Procter & Gamble logo with Consumer Staples background

Key Points

  • Eastern Bank has increased its position in Procter & Gamble by 13.5% in Q2, bringing its holdings to approximately $57 million, making the stock the 28th biggest position in their portfolio.
  • CEO Jon R. Moeller sold 40,119 shares of Procter & Gamble stock, leading to an 11.16% decrease in his holdings, while insider sales over the last ninety days totaled $23.4 million.
  • Analysts have adjusted their target prices for Procter & Gamble, with a consensus target now set at $172.21 and a mixed outlook with eleven Buy ratings versus nine Holds.
  • MarketBeat previews top five stocks to own in November.

Eastern Bank increased its position in Procter & Gamble Company (The) (NYSE:PG - Free Report) by 13.5% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 357,793 shares of the company's stock after purchasing an additional 42,456 shares during the quarter. Procter & Gamble makes up 1.1% of Eastern Bank's portfolio, making the stock its 28th biggest position. Eastern Bank's holdings in Procter & Gamble were worth $57,004,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in PG. Benjamin Edwards Inc. grew its position in shares of Procter & Gamble by 120.7% during the 1st quarter. Benjamin Edwards Inc. now owns 364,378 shares of the company's stock worth $62,098,000 after buying an additional 199,258 shares during the period. Capital Investment Advisory Services LLC grew its position in shares of Procter & Gamble by 13.8% during the 1st quarter. Capital Investment Advisory Services LLC now owns 37,709 shares of the company's stock worth $6,426,000 after buying an additional 4,562 shares during the period. World Investment Advisors grew its position in shares of Procter & Gamble by 6.0% during the 1st quarter. World Investment Advisors now owns 50,913 shares of the company's stock worth $8,677,000 after buying an additional 2,886 shares during the period. Concurrent Investment Advisors LLC grew its position in shares of Procter & Gamble by 26.4% during the 1st quarter. Concurrent Investment Advisors LLC now owns 120,002 shares of the company's stock worth $20,451,000 after buying an additional 25,059 shares during the period. Finally, Diversify Wealth Management LLC grew its position in shares of Procter & Gamble by 10.3% during the 1st quarter. Diversify Wealth Management LLC now owns 23,719 shares of the company's stock worth $3,849,000 after buying an additional 2,210 shares during the period. 65.77% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Procter & Gamble

In other news, CEO Jon R. Moeller sold 40,119 shares of the company's stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total transaction of $6,309,515.13. Following the sale, the chief executive officer owned 319,375 shares in the company, valued at $50,228,106.25. This represents a 11.16% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, CEO Gary A. Coombe sold 10,194 shares of the company's stock in a transaction that occurred on Thursday, August 21st. The stock was sold at an average price of $158.16, for a total value of $1,612,283.04. Following the sale, the chief executive officer owned 34,978 shares in the company, valued at approximately $5,532,120.48. This represents a 22.57% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 149,763 shares of company stock worth $23,421,279. 0.20% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

Several equities analysts have recently issued reports on the company. Barclays decreased their target price on Procter & Gamble from $164.00 to $153.00 and set an "equal weight" rating for the company in a research report on Wednesday, October 1st. Evercore ISI reiterated an "in-line" rating and set a $170.00 price objective (down previously from $190.00) on shares of Procter & Gamble in a report on Monday, July 14th. Weiss Ratings reiterated a "hold (c+)" rating on shares of Procter & Gamble in a report on Wednesday. BNP Paribas Exane cut their price objective on Procter & Gamble from $177.00 to $172.00 and set an "outperform" rating on the stock in a report on Tuesday, September 23rd. Finally, Bank of America cut their price objective on Procter & Gamble from $180.00 to $174.00 and set a "buy" rating on the stock in a report on Wednesday. Eleven research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $172.21.

Check Out Our Latest Stock Analysis on PG

Procter & Gamble Price Performance

Shares of PG opened at $149.69 on Friday. The stock has a market capitalization of $350.34 billion, a P/E ratio of 22.99, a P/E/G ratio of 3.99 and a beta of 0.36. Procter & Gamble Company has a twelve month low of $149.45 and a twelve month high of $180.43. The company has a 50 day moving average of $155.24 and a 200-day moving average of $159.53. The company has a quick ratio of 0.49, a current ratio of 0.70 and a debt-to-equity ratio of 0.49.

Procter & Gamble (NYSE:PG - Get Free Report) last issued its quarterly earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share for the quarter, topping the consensus estimate of $1.42 by $0.06. The company had revenue of $20.89 billion during the quarter, compared to analysts' expectations of $20.79 billion. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The business's quarterly revenue was up 1.7% on a year-over-year basis. During the same period last year, the business earned $1.40 EPS. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. As a group, equities research analysts forecast that Procter & Gamble Company will post 6.91 EPS for the current fiscal year.

Procter & Gamble Profile

(Free Report)

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

Further Reading

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG - Free Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Procter & Gamble Right Now?

Before you consider Procter & Gamble, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.

While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.